Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative esketamine for pain catastrophizing and chronic postsurgical pain after traumatic lower limb fractures
ChiCTR2500106619Phase 4Not yet recruiting
- Sponsor
- Tongling People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Persistent postsurgical pain (PPSP), acute postoperative pain, Pain catastrophizing (PC) and 2 more (2 arms), sponsored by Tongling People's Hospital. Primary endpoint: Chronic postsurgical pain. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Persistent postsurgical pain (PPSP)acute postoperative painPain catastrophizing (PC)anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2500106619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106619.